Combination of flavonoids from Oroxylum indicum seed extracts and acarbose improves the inhibition of postprandial blood glucose: In vivo and in vitro study

Biomedicine and Pharmacotherapy

Volumn 91, Issue , 2017, Pages 890-898

  Zhang, Bo wei ^a   Sang, Yuan bin ^a   Sun, Wen long ^a   Yu, He shui ^b   Ma, Bai ping ^b   Xiu, Zhi long ^a   Dong, Yue sheng ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Acarbose; Baicalein; Oroxylum indicum; Postprandial blood glucose; Synergism; Glucosidase

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; BAICALEIN; BAICALEIN 7 O DIGLUCOSIDE; BAICALEIN 7 O GLUCOSIDE; CHRYSIN; FLAVONOID; GLUCOSE; MALTOSE; MIGLITOL; OROXYLUM INDICUM SEED EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG; 1 DEOXYNOJIRIMYCIN; AMYLASE; ANTIDIABETIC AGENT; FLAVANONE DERIVATIVE;

ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIETARY SUPPLEMENT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HYDROLYSIS; IC50; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONHUMAN; OROXYLUM; PRIORITY JOURNAL; RAT; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BIGNONIACEAE; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; INTESTINE; METABOLISM; PANCREAS; PLANT SEED; POSTPRANDIAL STATE; SPRAGUE DAWLEY RAT;

1-DEOXYNOJIRIMYCIN; ACARBOSE; ALPHA-AMYLASES; ALPHA-GLUCOSIDASES; ANIMALS; BIGNONIACEAE; BLOOD GLUCOSE; DRUG SYNERGISM; FLAVANONES; FLAVONOIDS; HYPOGLYCEMIC AGENTS; INTESTINES; MALE; MICE; PANCREAS; PLANT EXTRACTS; POSTPRANDIAL PERIOD; RATS, SPRAGUE-DAWLEY; SEEDS;

EID: 85019089783     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.04.080     Document Type: Article

References (38)

1. [1] Portero McLellan, K.C., Wyne, K., Villagomez, E.T., Hsueh, W.A., Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus. Ther. Clin. Risk Manag. 10 (2014), 173–188.
2. [2] Bo, A., Creative use of novel glucose-lowering drugs for type 2 diabetes: where will we head in the next 50 years?. Diabetologia, 58, 2015.
3. [3] Englyst, K.N., Vinoy, S., Englyst, H.N., Lang, V., Glycaemic index of cereal products explained by their content of rapidly and slowly available glucose. Br. J. Nutr. 89:3 (2003), 329–339.
4. [4] Nichols, B.L., Avery, S., Sen, P., Swallow, D.M., Hahn, D., Sterchi, E., The maltase-glucoamylase gene: common ancestry to sucrase-isomaltase with complementary starch digestion activities. Proc. Natl. Acad. Sci. U. S. A. 100:3 (2003), 1432–1437.
5. [5] Rudovich, N., Pivovarova, O., Traberth, A., Sparwasser, A., Weickert, M.O., Bernigau, W., Birkenfeld, A.L., Arafat, A.M., Bergmann, A., Pfeiffer, A.F., Acarbose treatment enhances mid-regional pro-atrial natriuretic peptide concentrations in non-diabetic individuals: further evidence for a common cardiometabolic pathway?. Diabetologia 55:12 (2012), 3392–3395.
6. [6] Zhu, J.H., Zhang, D.Q., Chen, W.C., Managing ulcerative colitis by increasing hydrogen production via oral administration of Acarbose. AJTCAM 10:5 (2013), 356–359.
7. [7] Zhang, Y.Y., Hou, L.Q., Zhao, T.Y., Effects of acarbose on polycystic ovary syndrome: a meta-analysis. Exp. Clin. Endocr. Diabetes 122:6 (2014), 373–378.
8. [8] Han, C., Liu, T., A comparison of hypoglycemic activity of three species of basidiomycetes rich in vanadium. Biol. Trace Elem. Res. 127:2 (2009), 177–182.
9. [9] Etxeberria, U., de la Garza, A.L., Campion, J., Martinez, J.A., Milagro, F.I., Antidiabetic effects of natural plant extracts via inhibition of carbohydrate hydrolysis enzymes with emphasis on pancreatic alpha amylase. Expert Opin. Ther. Targets 16:3 (2012), 269–297.
10. [10] Yang, Y., Lian, G., Yu, B., ChemInform abstract: naturally occurring polyphenolic glucosidase inhibitors. Isr. J. Chem. 55:3–4 (2015), 268–284.
11. [11] Kumar, S., Narwal, S., Kumar, V., Prakash, O., alpha-glucosidase inhibitors from plants: a natural approach to treat diabetes. Pharmacogn. Rev. 5:9 (2011), 19–29.
12. [12] Hung, H.Y., Qian, K., Morris-Natschke, S.L., Hsu, C.S., Lee, K.H., Recent discovery of plant-derived anti-diabetic natural products. Nat. Prod. Rep. 29:5 (2012), 580–606.
13. [13] Akkarachiyasit, S., Yibchok-Anun, S., Wacharasindhu, S., Adisakwattana, S., In vitro inhibitory effects of cyandin-3-rutinoside on pancreatic alpha-amylase and its combined effect with acarbose. Molecules 16:3 (2011), 2075–2083.
14. [14] Boath, A.S., Stewart, D., McDougall, G.J., Berry components inhibit alpha-glucosidase in vitro: synergies between acarbose and polyphenols from black currant and rowanberry. Food Chem. 135:3 (2012), 929–936.
15. [15] Gao, J., Xu, P., Wang, Y., Wang, Y., Hochstetter, D., Combined effects of green tea extracts, green tea polyphenols or epigallocatechin gallate with acarbose on inhibition against alpha-amylase and alpha-glucosidase in vitro. Molecules 18:9 (2013), 11614–11623.
16. [16] Natori, Y., Imahori, T., Murakami, K., Yoshimura, Y., Nakagawa, S., Kato, A., Adachi, I., Takahata, H., The synthesis and biological evaluation of 1-C-alkyl-L-arabinoiminofuranoses, a novel class of alpha-glucosidase inhibitors. Bioorg. Med. Chem. Lett. 21:2 (2011), 738–741.
17. [17] Yan, R.Y., Cao, Y.Y., Chen, C.Y., Dai, H.Q., Yu, S.X., Wei, J.L., Li, H., Yang, B., Antioxidant flavonoids from the seed of Oroxylum indicum. Fitoterapia 82:6 (2011), 841–848.
18. [18] Mat Ali, R., Houghton, P.J., Raman, A., Hoult, J.R., Antimicrobial and antiinflammatory activities of extracts and constituents of Oroxylum indicum (L.) Vent. Phytomedicine 5:5 (1998), 375–381.
19. [19] Costa-Lotufo, L.V., Khan, M.T., Ather, A., Wilke, D.V., Jimenez, P.C., Pessoa, C., de Moraes, M.E., de Moraes, M.O., Studies of the anticancer potential of plants used in Bangladeshi folk medicine. J. Ethnopharmacol. 99:1 (2005), 21–30.
20. [20] Sun, W., Sang, Y., Zhang, B., Yu, X., Xu, Q., Xiu, Z., Dong, Y., Synergistic effects of acarbose and an Oroxylum indicum seed extract in streptozotocin and high-fat-diet induced prediabetic mice. Biomed. Pharmacother. 87 (2017), 160–170.
21. [21] Chen, L.J., Games, D.E., Jones, J., Isolation and identification of four flavonoid constituents from the seeds of Oroxylum indicum by high-speed counter-current chromatography. J. Chromatogr. A 988:1 (2003), 95–105.
22. [22] Nair, A.G.R., Joshi, B.S., Oroxindin—a new flavone glucuronide from Oroxylum indicum Vent. J. Chem. Sci. 88:5 (1979), 323–327.
23. [23] Lai, M.Y., Hsiu, S.L., Tsai, S.Y., Hou, Y.C., Chao, P.D., Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats. J. Pharm. Pharmacol. 55:2 (2003), 205–209.
24. [24] Yang, Y., Lian, G., Yu, B., Naturally occurring polyphenolic glucosidase inhibitors. Isr. J. Chem. 55:3–4 (2015), 268–284.
25. [25] Ghosh, S., Ahire, M., Patil, S., Jabgunde, A., Bhat Dusane, M., Joshi, B.N., Pardesi, K., Jachak, S., Dhavale, D.D., Chopade, B.A., Antidiabetic activity of Gnidia glauca and Dioscorea bulbifera: potent amylase and glucosidase inhibitors. Evid.-Based Complement. Altern., 2012, 2012, 929051.
26. [26] Yasuda, M., Yasutake, K., Hino, M., Ohwatari, H., Ohmagari, N., Takedomi, K., Tanaka, T., Nonaka, G., Inhibitory effects of polyphenols from water chestnut (Trapa japonica) husk on glycolytic enzymes and postprandial blood glucose elevation in mice. Food Chem. 165 (2014), 42–49.
27. [27] Chou, T.-C., Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 58:3 (2006), 621–681.
28. [28] Ban, J.O., Hwang, C.J., Park, M.H., Hwang, I.K., Jeong, H.S., Lee, H.P., Hyun, B.K., Kim, J.Y., Youn, H.S., Ham, Y.W., Yoon do, Y., Han, S.B., Song, M.J., Hong, J.T., Enhanced cell growth inhibition by thiacremonone in paclitaxel-treated lung cancer cells. Arch. Pharm. Res. 38:7 (2015), 1351–1362.
29. [29] Tang, L.Q., Wei, W., Chen, L.M., Liu, S., Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J. Ethnopharmacol. 108:1 (2006), 109–115.
30. [30] Satoh, T., Igarashi, M., Yamada, S., Takahashi, N., Watanabe, K., Inhibitory effect of black tea and its combination with acarbose on small intestinal alpha-glucosidase activity. J. Ethnopharmacol. 161 (2015), 147–155.
31. [31] Federiuk, I.F., Casey, H.M., Quinn, M.J., Wood, M.D., Ward, W.K., Induction of type-1 diabetes mellitus in laboratory rats by use of alloxan: route of administration, pitfalls, and insulin treatment. Comp. Med. 54:3 (2004), 252–257.
32. [32] Naveen Kumar, D.R., Cijo George, V., Suresh, P.K., Ashok Kumar, R., Cytotoxicity, apoptosis induction and anti-metastatic potential of Oroxylum indicum in human breast cancer cells. Asian Pac. J. Cancer Prev. 13:6 (2012), 2729–2734.
33. [33] Pantidos, N., Boath, A., Lund, V., Conner, S., McDougall, G.J., Phenolic-rich extracts from the edible seaweed, ascophyllum nodosum, inhibit α-amylase and α-glucosidase: potential anti-hyperglycemic effects. J. Funct. Foods 10 (2014), 201–209.
34. [34] Gao, H., Nishioka, T., Kawabata, J., Kasai, T., Structure-activity relationships for alpha-glucosidase inhibition of baicalein, 5,6,7-trihydroxyflavone: the effect of A-ring substitution. Biosci. Biotechnol. Biochem. 68:2 (2004), 369–375.
35. [35] Adisakwattana, S., Yibchok-Anun, S., Charoenlertkul, P., Wongsasiripat, N., Cyanidin-3-rutinoside alleviates postprandial hyperglycemia and its synergism with acarbose by inhibition of intestinal alpha-glucosidase. J. Clin. Biochem. Nutr. 49:1 (2011), 36–41.
36. [36] Grodsky, G.M., Anderson, C.E., Coleman, D.L., Craighead, J.E., Gerritsen, G.C., Hansen, C.T., Herberg, L., Howard, C.F. Jr., Lernmark, A., Matschinsky, F.M., Rayfield, E., Riley, W.J., Rossini, A.A., Metabolic and underlying causes of diabetes mellitus. Diabetes 31:Suppl. 1 Pt 2 (1982), 45–53.
37. [37] Sirovina, D., Orsolic, N., Koncic, M.Z., Kovacevic, G., Benkovic, V., Gregorovic, G., Quercetin vs chrysin: effect on liver histopathology in diabetic mice. Hum. Exp. Toxicol. 32:10 (2013), 1058–1066.
38. [38] Fu, Y., Luo, J., Jia, Z., Zhen, W., Zhou, K., Gilbert, E., Liu, D., Baicalein protects against type 2 diabetes via promoting islet beta-cell function in obese diabetic mice. Int. J. Endocrinol. 2014 (2014), 1–13.